Evidence map›Paper›PMID 21887704›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2011

The critical role of the epidermal growth factor receptor in endochondral ossification.

Xianrong Zhang, Valerie A Siclari, Shenghui Lan, Ji Zhu, Eiki Koyama, Holly L Dupuis, Motomi Enomoto-Iwamoto, Frank Beier, Ling Qin

Open access · greenAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Biomedicines · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. EGFR Signaling Is Required for Maintaining Adult Cartilage Homeostasis and Attenuating Osteoarthritis Progression.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  13. Regulatory Mechanisms ofInternational journal of molecular sciences · 2022
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Role of iRhoms 1 and 2 in Endochondral Ossification.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Xianrong ZhangDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Valerie A Siclari
Shenghui Lan
Ji Zhu
Eiki Koyama
Holly L Dupuis
Motomi Enomoto-Iwamoto
Frank Beier
Ling Qin
University of Pennsylvania · USChildren's Hospital of Philadelphia · USWestern University · CA

Funding

Mechanisms of Synovial Joint FormationR01AR062908 · NIAMS · CHILDREN'S HOSP OF PHILADELPHIA · PI ENOMOTO-IWAMOTO, MOTOMI, PACIFICI, MAURIZIO · 2011 to 2020
$4.5M
Mechanisms of Synovial Joint FormationR01AG025868 · NIA · THOMAS JEFFERSON UNIVERSITY · PI PACIFICI, MAURIZIO · 2005 to 2009
$1.8M
The role of amphiregulin in PTH's action on boneK01DK071988 · NIDDK · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI QIN, LING · 2005 to 2008
$531k
CIHR 86574NIAMS NIH HHS R01 AR062908NIA NIH HHS R01 AG025868NIDDK NIH HHS DK071988NIDDK NIH HHS K01 DK071988
6 · The paper itself

Abstract

Loss of epidermal growth factor receptor (EGFR) activity in mice alters growth plate development, impairs endochondral ossification, and retards growth. However, the detailed mechanism by which EGFR regulates endochondral bone formation is unknown. Here, we show that administration of an EGFR-specific small-molecule inhibitor, gefitinib, into 1-month-old rats for 7 days produced profound defects in long bone growth plate cartilage characterized by epiphyseal growth plate thickening and massive accumulation of hypertrophic chondrocytes. Immunostaining demonstrated that growth plate chondrocytes express EGFR, but endothelial cells and osteoclasts show little to no expression. Gefitinib did not alter chondrocyte proliferation or differentiation and vascular invasion into the hypertrophic cartilage. However, osteoclast recruitment and differentiation at the chondro-osseous junction were attenuated owing to decreased RANKL expression in the growth plate. Moreover, gefitinib treatment inhibited the expression of matrix metalloproteinases (MMP-9, -13, and -14), increased the amount of collagen fibrils, and decreased degraded extracellular matrix products in the growth plate. In vitro, the EGFR ligand transforming growth factor α (TGF-α) strongly stimulated RANKL and MMPs expression and suppressed osteoprotegerin (OPG) expression in primary chondrocytes. In addition, a mouse model of cartilage-specific EGFR inactivation exhibited a similar phenotype of hypertrophic cartilage enlargement. Together our data demonstrate that EGFR signaling supports osteoclastogenesis at the chondro-osseous junction and promotes chondrogenic expression of MMPs in the growth plate. Therefore, we conclude that EGFR signaling plays an essential role in the remodeling of growth plate cartilage extracellular matrix into bone during endochondral ossification.

Indexed as

OsteogenesisAnimalsBone and BonesCalcification, PhysiologicCartilageCell DifferentiationCell ProliferationCells, CulturedChondrocytesErbB ReceptorsGefitinibGrowth PlateHypertrophyMatrix MetalloproteinasesMiceNeovascularization, PhysiologicErbB ReceptorsGefitinibMatrix MetalloproteinasesQuinazolines

Identifiers

PMID21887704
PMCPMC3200483
OpenAlexW2080000503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.